Commentary
Ideas and insights on pressing issues facing the business world.
By Charles Walldorf and The ConversationMarch 11, 2026
AI can double output. Human biology can’t
By Scott HutchesonMarch 10, 2026
Latest Stories
By The Associated Press and Seth BorensteinMarch 11, 2026
AI‘Proceed with caution’: Elon Musk offers warning after Amazon reportedly held mandatory meeting to address ‘high blast radius’ AI-related incident
By Sasha RogelbergMarch 11, 2026
EnergyTrump says the U.S. will open its first new oil refinery in nearly 50 years as the U.S. military avoids bombing Iran’s oil infrastructure
By Jacqueline MunisMarch 11, 2026
By Emily PharesMarch 11, 2026
By Joseph HostetlerMarch 11, 2026
More CommentaryPage 30 of 100
CommentaryLong before Polymarket, election polls and predictions were always a form of popular entertainment with a checkered record of accuracy
By W. Joseph CampbellOctober 29, 2024
CommentaryThe U.S. sports boom is a unique opportunity for European investors—without many of the old continent’s risks
By Robin LauberOctober 29, 2024
By Blessing AdesiyanOctober 29, 2024
By Adrian BlairOctober 28, 2024
CommentaryWhy U.K. Chancellor Rachel Reeves should approach capital gains tax decisions like a venture capitalist
By James McClureOctober 28, 2024
By Caroline HodgeOctober 25, 2024
CommentaryEV charging stations could become America’s next ‘third place’ as they partner with grocers and coffee shops
By Andrew CorneliaOctober 25, 2024
By Craig BarrettOctober 25, 2024
By Luba Kassova and Richard AddyOctober 25, 2024
By Chris Bradley and Michael BirshanOctober 24, 2024
CommentaryAs activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
By Jeffrey Sonnenfeld and Steven TianOctober 24, 2024
CommentaryHow the Biden-Harris administration wrote insurers a $10 billion check to cover up the predictable impact of an IRA provision
By Tomas J. PhilipsonOctober 24, 2024
CommentaryOzempic and Wegovy are trimming waistlines—and showing how quickly U.S. health care can turn into a gold rush
By Owen TrippOctober 23, 2024
CommentaryDespite inflation, U.S. consumers are 5% better off than in 2019—here’s why they don’t feel that way
By Philipp Carlsson-Szlezak and Paul SwartzOctober 23, 2024
CommentaryThe defunct AmazonSmile charitable program worked. I know because I co-founded Tripadvisor using the same principles
By Steve KauferOctober 23, 2024
By Julie WainwrightOctober 22, 2024
CommentaryWarren Buffett warns of ‘casino-like’ investor behavior. Here’s the hidden cost of ‘free’ investing
By Victor Haghani, James White and Vladimir RagulinOctober 22, 2024
CommentaryWhy breaking Intel in two is the only way to save America’s most important manufacturer, according to its former board directors
By David B. Yoffie, Reed Hundt, Charlene Barshefsky and James PlummerOctober 22, 2024
CommentaryHere’s what it would take for Europe to successfully compete with the U.S. and China, according to EY
By Julie Linn TeiglandOctober 22, 2024
CommentaryBiden-Harris have a track record of real success in bringing manufacturing back to America. Trump’s all-sticks-no-carrots approach already failed
By Jeffrey Sonnenfeld, Laura Tyson and Steven TianOctober 21, 2024
CommentaryGovernments have just 5 weeks to end plastic pollution. A global, binding treaty is the only solution
By Ellen MacArthur and Christiana FigueresOctober 21, 2024
By Keith FerrazziOctober 18, 2024
CommentaryThe next wave of AI won’t be driven by LLMs. Here’s what investors should focus on instead
By Vivek WadhwaOctober 18, 2024
By Gillian HadfieldOctober 17, 2024
By Oskar SerranderOctober 17, 2024
CommentaryThe world needs innovative antiviral drugs—but market incentives won’t align until it’s too late, Germany’s ‘head of challenges’ warns
By Jano CostardOctober 16, 2024
By Bob GoodsonOctober 16, 2024
Partner CommentaryNavigating the new world of work: 3 leadership imperatives to future-proof your organization
By Bijal ShahOctober 15, 2024
By Neeru PahariaOctober 15, 2024
Most Popular
